References(64)
[1]
Wei, H.; Bruns, O. T.; Kaul, M. G.; Hansen, E. C.; Barch, M.; Wiśniowska, A.; Chen, O.; Chen, Y.; Li, N.; Okada, S. et al. Exceedingly small iron oxide nanoparticles as positive MRI contrast agents. Proc. Natl. Acad. Sci. U.S.A 2017, 114, 2325-2330.
[2]
Hachani, R.; Lowdell, M.; Birchall, M.; Hervault, A.; Mertz, D.; Begin-Colin, S.; Thanh, N. T. K. Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents. Nanoscale 2016, 8, 3278-3287.
[3]
Blanco-Andujar, C.; Walter, A.; Cotin, G.; Bordeianu, C.; Mertz, D.; Felder-Flesch, D.; Begin-Colin, S. Design of iron oxide-based nanoparticles for MRI and magnetic hyperthermia. Nanomedicine 2016, 11, 1889-1910.
[4]
Cotin, G.; Blanco-Andujar, C.; Nguyen, D. V.; Affolter, C.; Boutry, S.; Boos, A.; Ronot, P.; Uring-Lambert, B.; Choquet, P.; Zorn, P. E. et al. Dendron based antifouling, MRI and magnetic hyperthermia properties of different shaped iron oxide nanoparticles. Nanotechnology 2019, 30, 374002.
[5]
Cortajarena, A. L.; Ortega, D.; Ocampo, S. M.; Gonzalez-García, A.; Couleaud, P.; Miranda, R.; Belda-Iniesta, C.; Ayuso-Sacido, A. Engineering iron oxide nanoparticles for clinical settings. Nanobiomedicine 2014, 1, 2.
[6]
Johannsen, M.; Thiesen, B.; Wust, P.; Jordan, A. Magnetic nanoparticle hyperthermia for prostate cancer. Int. J. Hyperthermia 2010, 26, 790-795.
[7]
Blanco-Andujar, C.; Teran, F. J.; Ortega, D. Current outlook and perspectives on nanoparticle-mediated magnetic hyperthermia. In Iron Oxide Nanoparticles for Biomedical Applications. Mahmoudi, M.; Laurent, S., Eds.; Metal Oxides: Elsevier, 2018; pp 197-245.
[8]
Maier-Hauff, K.; Ulrich, F.; Nestler, D.; Niehoff, H.; Wust, P.; Thiesen, B.; Orawa, H.; Budach, V.; Jordan, A. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J. Neurooncol. 2011, 103, 317-324.
[9]
Espinosa, A.; Kolosnjaj-Tabi, J.; Abou-Hassan, A.; Sangnier, A. P.; Curcio, A.; Silva, A. K. A.; Di Corato, R.; Neveu, S.; Pellegrino, T.; Liz-Marzán, L. M. et al. Magnetic (Hyper)thermia or photothermia? Progressive comparison of iron oxide and gold nanoparticles heating in water, in cells, and in vivo. Adv. Funct. Mater. 2018, 28, 1803660.
[10]
Kakwere, H.; Leal, M. P.; Materia, M. E.; Curcio, A.; Guardia, P.; Niculaes, D.; Marotta, R.; Falqui, A.; Pellegrino, T. Functionalization of strongly interacting magnetic nanocubes with (thermo)responsive coating and their application in hyperthermia and heat-triggered drug delivery. ACS Appl. Mater. Interfaces 2015, 7, 10132-10145.
[11]
Sandre, O.; Genevois, C.; Garaio, E.; Adumeau, L.; Mornet, S.; Couillaud, F. In vivo imaging of local gene expression induced by magnetic hyperthermia. Genes 2017, 8, 61.
[12]
Cazares-Cortes, E.; Cabana, S.; Boitard, C.; Nehlig, E.; Griffete, N.; Fresnais, J.; Wilhelm, C.; Abou-Hassan, A.; Ménager, C. Recent insights in magnetic hyperthermia: From the “hot-spot” effect for local delivery to combined magneto-photo-thermia using magneto-plasmonic hybrids. Adv. Drug Deliv. Rev. 2019, 138, 233-246.
[13]
Blanco-Andujar, C.; Ortega, D.; Southern, P.; Pankhurst, Q. A.; Thanh, N. T. K. High performance multi-core iron oxide nanoparticles for magnetic hyperthermia: Microwave synthesis, and the role of core-to-core interactions. Nanoscale 2015, 7, 1768-1775.
[14]
Asensio, J. M.; Marbaix, J.; Mille, N.; Lacroix, L. M.; Soulantica, K.; Fazzini, P. F.; Carrey, J.; Chaudret, B. To heat or not to heat: A study of the performances of iron carbide nanoparticles in magnetic heating. Nanoscale 2019, 11, 5402-5411.
[15]
Hallali, N.; Clerc, P.; Fourmy, D.; Gigoux, V.; Carrey, J. Influence on cell death of high frequency motion of magnetic nanoparticles during magnetic hyperthermia experiments. Appl. Phys. Lett. 2016, 109, 032402.
[16]
Plan Sangnier, A.; Preveral, S.; Curcio, A.; Silva, A. K. A.; Lefèvre, C. T.; Pignol, D.; Lalatonne, Y.; Wilhelm, C. Targeted thermal therapy with genetically engineered magnetite magnetosomes@RGD: Photothermia is far more efficient than magnetic hyperthermia. J. Control. Release 2018, 279, 271-281.
[17]
Chu, M. Q.; Shao, Y. X.; Peng, J. L.; Dai, X. Y.; Li, H. K.; Wu, Q. S.; Shi, D. L. Near-infrared laser light mediated cancer therapy by photothermal effect of Fe3O4 magnetic nanoparticles. Biomaterials 2013, 34, 4078-4088.
[18]
Zhou, Z. G.; Sun, Y. N.; Shen, J. C.; Wei, J.; Yu, C.; Kong, B.; Liu, W.; Yang, H.; Yang, S. P.; Wang, W. Iron/iron oxide core/shell nanoparticles for magnetic targeting MRI and near-infrared photothermal therapy. Biomaterials 2014, 35, 7470-7478.
[19]
Shen, S.; Wang, S.; Zheng, R.; Zhu, X. Y.; Jiang, X. G.; Fu, D. L.; Yang, W. L. Magnetic nanoparticle clusters for photothermal therapy with near-infrared irradiation. Biomaterials 2015, 39, 67-74.
[20]
Ye, D. W.; Li, Y.; Gu, N. Magnetic labeling of natural lipid encapsulations with iron-based nanoparticles. Nano Res. 2018, 11, 2970-2991.
[21]
Ulbrich, K.; Holá, K.; Šubr, V.; Bakandritsos, A.; Tuček, J.; Zbořil, R. Targeted drug delivery with polymers and magnetic nanoparticles: Covalent and noncovalent approaches, release control, and clinical studies. Chem. Rev. 2016, 116, 5338-5431.
[22]
Carregal-Romero, S.; Guardia, P.; Yu, X.; Hartmann, R.; Pellegrino, T.; Parak, W. J. Magnetically triggered release of molecular cargo from iron oxide nanoparticle loaded microcapsules. Nanoscale 2015, 7, 570-576.
[23]
Mertz, D.; Sandre, O.; Bégin-Colin, S. Drug releasing nanoplatforms activated by alternating magnetic fields. Biochim. Biophys. Acta Gen. Subj. 2017, 1861, 1617-1641.
[24]
Adedoyin, A. A.; Ekenseair, A. K. Biomedical applications of magneto-responsive scaffolds. Nano Res. 2018, 11, 5049-5064.
[25]
Souza, G. R.; Molina, J. R.; Raphael, R. M.; Ozawa, M. G.; Stark, D. J.; Levin, C. S.; Bronk, L. F.; Ananta, J. S.; Mandelin, J.; Georgescu, M. M. et al. Three-dimensional tissue culture based on magnetic cell levitation. Nat. Nanotechnol, 2010, 5, 291-296.
[26]
Mattix, B.; Olsen, T. R.; Gu, Y.; Casco, M.; Herbst, A.; Simionescu, D. T.; Visconti, R. P.; Kornev, K. G.; Alexis, F. Biological magnetic cellular spheroids as building blocks for tissue engineering. Acta Biomater. 2014, 10, 623-629.
[27]
Hachani, R.; Lowdell, M.; Birchall, M.; Thanh, N. T. K. Tracking stem cells in tissue-engineered organs using magnetic nanoparticles. Nanoscale 2013, 5, 11362-11373.
[28]
Pham, B. T. T.; Colvin, E. K.; Pham, N. T. H.; Kim, B. J.; Fuller, E. S.; Moon, E. A.; Barbey, R.; Yuen, S.; Rickman, B. H.; Bryce, N. S. et al. Biodistribution and clearance of stable superparamagnetic maghemite iron oxide nanoparticles in mice following intraperitoneal administration. Int. J. Mol. Sci. 2018, 19, 205.
[29]
Bargheer, D.; Giemsa, A.; Freund, B.; Heine, M.; Waurisch, C.; Stachowski, G. M.; Hickey, S. G.; Eychmüller, A.; Heeren, J.; Nielsen, P. The distribution and degradation of radiolabeled superparamagnetic iron oxide nanoparticles and quantum dots in mice. Beilstein J. Nanotechnol. 2015, 6, 111-123.
[30]
Freund, B.; Tromsdorf, U. I.; Bruns, O. T.; Heine, M.; Giemsa, A.; Bartelt, A.; Salmen, S. C.; Raabe, N.; Heeren, J.; Ittrich, H. et al. A simple and widely applicable method to 59Fe-radiolabel monodisperse superparamagnetic iron oxide nanoparticles for in vivo quantification studies. ACS Nano 2012, 6, 7318-7325.
[31]
Singh, S. P.; Rahman, M. F.; Murty, U. S. N.; Mahboob, M.; Grover, P. Comparative study of genotoxicity and tissue distribution of nano and micron sized iron oxide in rats after acute oral treatment. Toxicol. Appl. Pharmacol. 2013, 266, 56-66.
[32]
Gu, L.; Fang, R. H.; Sailor, M. J.; Park, J. H. In vivo clearance and toxicity of monodisperse iron oxide nanocrystals. ACS Nano 2012, 6, 4947-4954.
[33]
Mazuel, F.; Espinosa, A.; Luciani, N.; Reffay, M.; Le Borgne, R.; Motte, L.; Desboeufs, K.; Michel, A.; Pellegrino, T.; Lalatonne, Y. et al. Massive intracellular biodegradation of iron oxide nanoparticles evidenced magnetically at single-endosome and tissue levels. ACS Nano 2016, 10, 7627-7638.
[34]
Plan Sangnier, A.; Van De Walle, A. B.; Curcio, A.; Le Borgne, R.; Motte, L.; Lalatonne, Y.; Wilhelm, C. Impact of magnetic nanoparticle surface coating on their long-term intracellular biodegradation in stem cells. Nanoscale 2019, 11, 16488-16498.
[35]
Van De Walle, A.; Plan Sangnier, A.; Abou-Hassan, A.; Curcio, A.; Hémadi, M.; Menguy, N.; Lalatonne, Y.; Luciani, N.; Wilhelm, C. Biosynthesis of magnetic nanoparticles from nano-degradation products revealed in human stem cells. Proc. Natl. Acad. Sci. USA 2019, 116, 4044-4053.
[36]
Hemery, G.; Garanger, E.; Lecommandoux, S.; Wong, A. D.; Gillies, E. R.; Pedrono, B.; Bayle, T.; Jacob, D.; Sandre, O. Thermosensitive polymer-grafted iron oxide nanoparticles studied by in situ dynamic light backscattering under magnetic hyperthermia. J. Phys. D.: Appi. Phys. 2015, 48, 494001.
[37]
Wang, L.; Wang, Z. J.; Li, X. M.; Zhang, Y.; Yin, M.; Li, J.; Song, H. Y.; Shi, J. Y.; Ling, D. S.; Wang, L. H. et al. Deciphering active biocompatibility of iron oxide nanoparticles from their intrinsic antagonism. Nano Res. 2018, 11, 2746-2755.
[38]
Wilhelm, C.; Gazeau, F. Universal cell labelling with anionic magnetic nanoparticles. Biomaterials 2008, 29, 3161-3174.
[39]
Negi, H.; Takeuchi, S.; Kamei, N.; Yanada, S.; Adachi, N.; Ochi, M. In vitro safety and quality of magnetically labeled human mesenchymal stem cells preparation for cartilage repair. Tissue Eng. Part C: Methods 2019, 25, 324-333.
[40]
Van De Walle, A.; Faissal, W.; Wilhelm, C.; Luciani, N. Role of growth factors and oxygen to limit hypertrophy and impact of high magnetic nanoparticles dose during stem cell chondrogenesis. Comput. Struct. Biotechnol. J. 2018, 16, 532-542.
[41]
Chang, Y. K.; Liu, Y. P.; Ho, J. H.; Hsu, S. C.; Lee, O. K. Amine-surface-modified superparamagnetic iron oxide nanoparticles interfere with differentiation of human mesenchymal stem cells. J. Orthop. Res. 2012, 30, 1499-1506.
[42]
Chen, Y. C.; Hsiao, J. K.; Liu, H. M.; Lai, I. Y.; Yao, M.; Hsu, S. C.; Ko, B. S.; Chen, Y. C.; Yang, C. S.; Huang, D. M. The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells. Toxicol. Appl. Pharmacol. 2010, 245, 272-279.
[43]
Huang, D. M.; Hsiao, J. K.; Chen, Y. C.; Chien, L. Y.; Yao, M.; Chen, Y. K.; Ko, B. S.; Hsu, S. C.; Tai, L. A.; Cheng, H. Y. The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles. Biomaterials 2009, 30, 3645-3651.
[44]
Roeder, E.; Henrionnet, C.; Goebel, J. C.; Gambier, N.; Beuf, O.; Grenier, D.; Chen, B. L.; Vuissoz, P. A.; Gillet, P.; Pinzano, A. Dose-response of superparamagnetic iron oxide labeling on mesenchymal stem cells chondrogenic differentiation: A multi-scale in vitro study. PLoS One 2014, 9, e98451.
[45]
Nikitin, P. I.; Vetoshko, P. M.; Ksenevich, T. I. New type of biosensor based on magnetic nanoparticle detection. J. Magn. Magn. Mater. 2007, 311, 445-449.
[46]
Lenglet, L.; Motte, L. Neel effect: Exploiting the nonlinear behavior of superparamagnetic nanoparticles for applications in life sciences up to electrical engineering. In Novel Magnetic Nanostructures. Domracheva, N.; Caporali, M.; Rentschler, E., Eds.; Elsevier: Amsterdam, 2018; pp 247-265.
[47]
Richard, S.; Eder, V.; Caputo, G.; Journé, C.; Ou, P.; Bolley, J.; Louedec, L.; Guenin, E.; Motte, L.; Pinna, N. et al. USPIO size control through microwave nonaqueous sol-gel method for neoangiogenesis T2 MRI contrast agent. Nanomedicine (Lond) 2016, 11, 2769-2779.
[48]
Motte, L.; Benyettou, F.; De Beaucorps, C.; Lecouvey, M.; Milesovic, I.; Lalatonne, Y. Multimodal superparamagnetic nanoplatform for clinical applications: Immunoassays, imaging & therapy. Faraday Discuss. 2011, 149, 211-225.
[49]
Kostura, L.; Kraitchman, D. L.; Mackay, A. M.; Pittenger, M. F.; Bulte, J. W. M. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 2004, 17, 513-517.
[50]
Assa, F.; Jafarizadeh-Malmiri, H.; Ajamein, H.; Anarjan, N.; Vaghari, H.; Sayyar, Z.; Berenjian, A. A biotechnological perspective on the application of iron oxide nanoparticles. Nano Res. 2016, 9, 2203-2225.
[51]
Tamion, A.; Hillenkamp, M.; Hillion, A.; Maraloiu, V. A.; Vlaicu, I. D.; Stefan, M.; Ghica, D.; Rositi, H.; Chauveau, F.; Blanchin, M. G. et al. Ferritin surplus in mouse spleen 14 months after intravenous injection of iron oxide nanoparticles at clinical dose. Nano Res. 2016, 9, 2398-2410.
[52]
Nikitin, P. I.; Vetoshko, P. M.; Ksenevich, T. I. Magnetic immunoassays. Sens. Lett. 2007, 5, 296-299.
[53]
Guénin, E.; Lalatonne, Y.; Bolley, J.; Milosevic, I.; Platas-Iglesias, C.; Motte, L. Catechol versus bisphosphonate ligand exchange at the surface of iron oxide nanoparticles: Towards multi-functionalization. J. Nanopart. Res. 2014, 16, 2596.
[54]
Milosevic, I.; Warmont, F.; Lalatonne, Y.; Motte, L. Magnetic metrology for iron oxide nanoparticle scaled-up synthesis. RSC Adv. 2014, 4, 49086-49089.
[55]
Geinguenaud, F.; Souissi, I.; Fagard, R.; Motte, L.; Lalatonne, Y. Electrostatic assembly of a DNA superparamagnetic nano-tool for simultaneous intracellular delivery and in situ monitoring. Nanomedicine 2012, 8, 1106-1115.
[56]
Geinguenaud, F.; Souissi, I.; Fagard, R.; Lalatonne, Y.; Motte, L. Easily controlled grafting of oligonucleotides on γFe2O3 Nanoparticles: Physicochemical characterization of DNA organization and biological activity studies. J. Phys. Chem. B 2014, 118, 1535-1544.
[57]
Benyettou, F.; Fahs, H.; Elkharrag, R.; Bilbeisi, R. A.; Asma, B.; Rezgui, R.; Motte, L.; Magzoub, M.; Brandel, J.; Olsen, J. C. et al. Selective growth inhibition of cancer cells with doxorubicin-loaded CB[7]-modified iron-oxide nanoparticles. RSC Adv. 2017, 7, 23827-23834.
[58]
Nikitin, M. P.; Vetoshko, P. M.; Brusentsov, N. A.; Nikitin, P. I. Highly sensitive room-temperature method of non-invasive in vivo detection of magnetic nanoparticles. J. Magn. Magn. Mater. 2009, 321, 1658-1661.
[59]
Nikitin, M.; Yuriev, M.; Brusentsov, N.; Vetoshko, P.; Nikitin, P. Non-invasive in vivo mapping and long-term monitoring of magnetic nanoparticles in different organs of animals. AIP Conf. Proc. 2010, 1311, 452-457.
[60]
De Montferrand, C.; Hu, L.; Milosevic, I.; Russier, V.; Bonnin, D.; Motte, L.; Brioude, A.; Lalatonne, Y. Iron oxide nanoparticles with sizes, shapes and compositions resulting in different magnetization signatures as potential labels for multiparametric detection. Acta Biomater. 2013, 9, 6150-6157.
[61]
Arbab, A. S.; Wilson, L. B.; Ashari, P.; Jordan, E. K.; Lewis, B. K.; Frank, J. A. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: Implications for cellular magnetic resonance imaging. NMR Biomed. 2005, 18, 383-389.
[62]
Gutiérrez, L.; Romero, S.; Da Silva, G. B.; Costo, R.; Vargas, M. D.; Ronconi, C. M.; Serna, C. J.; Veintemillas-Verdaguer, S.; Del Puerto Morales, M. Degradation of magnetic nanoparticles mimicking lysosomal conditions followed by AC susceptibility. Biomed. Tech. (Berl) 2015, 60, 417-425.
[63]
Soenen, S. J. H.; Himmelreich, U.; Nuytten, N.; Pisanic II, T. R.; Ferrari, A.; De Cuyper, M. Intracellular nanoparticle coating stability determines nanoparticle diagnostics efficacy and cell functionality. Small 2010, 6, 2136-2145.
[64]
Garcés, V.; Rodríguez-Nogales, A.; González, A.; Gálvez, N.; Rodríguez-Cabezas, M. E.; García-Martin, M. L.; Gutiérrez, L.; Rondón, D.; Olivares, M.; Gálvez, J. et al. Bacteria-carried iron oxide nanoparticles for treatment of anemia. Bioconjugate Chem. 2018, 29, 1785-1791.